CA2213507A1 — Pharmaceutical composition for treating transient ischemic attack
Assigned to Takeda Pharmaceutical Co Ltd · Expires 1996-08-29 · 30y expired
What this patent protects
A pharmaceutical composition for treating a transient ischemic attack which comprises a compound of formula (I), wherein R1 is a pyridyl group, R2 is a phenyl, thienyl, furyl, naphthyl, benzothienyl or pyridyl group, which may be substituted with a lower alkoxy group, a lower alk…
USPTO Abstract
A pharmaceutical composition for treating a transient ischemic attack which comprises a compound of formula (I), wherein R1 is a pyridyl group, R2 is a phenyl, thienyl, furyl, naphthyl, benzothienyl or pyridyl group, which may be substituted with a lower alkoxy group, a lower alkyl group, a halogen atom, trifluoromethyl group, a lower alkenyl group or/and methylenedioxy group, R3 is hydrogen atom or a lower alkyl group, and l is an integer of 0 to 6, Y is sulfur atom, methylene group or a group of formula (a), wherein R4 is hydrogen atom or acetyl group, and m is 0 or 1, or a pharmaceutically acceptable salt.
Drugs covered by this patent
- Colcrys (COLCHICINE) · Scilex Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.